Compare JMIA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JMIA | CYRX |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | Germany | United States |
| Employees | N/A | 1100 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.9M | 814.9M |
| IPO Year | 2018 | 2008 |
| Metric | JMIA | CYRX |
|---|---|---|
| Price | $6.11 | $17.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $12.13 | ★ $19.78 |
| AVG Volume (30 Days) | ★ 1.2M | 642.0K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $26.10 | $10.96 |
| Revenue Next Year | $24.21 | $10.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.59 | $7.61 |
| 52 Week High | $14.72 | $18.36 |
| Indicator | JMIA | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 51.42 |
| Support Level | $5.70 | $14.55 |
| Resistance Level | $6.29 | $18.17 |
| Average True Range (ATR) | 0.26 | 0.61 |
| MACD | -0.11 | -0.13 |
| Stochastic Oscillator | 32.78 | 41.00 |
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.